id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-3539-0005,FDA,FDA-2024-E-3539,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2025-11-24T05:00:00Z,2025,11,2025-11-24T05:00:00Z,,2025-11-25T02:52:58Z,,0,0,09000064b9094027
FDA-2024-E-3539-0004,FDA,FDA-2024-E-3539,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-09-11T04:00:00Z,2025,9,2025-09-11T04:00:00Z,,2025-09-11T17:09:26Z,,0,0,09000064b8f52891
FDA-2024-E-3539-0003,FDA,FDA-2024-E-3539,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2025-08-13T04:00:00Z,2025,8,2025-08-13T04:00:00Z,,2025-08-13T23:26:44Z,,0,0,09000064b8ef9b11